Special Interest Group (SIG)

Phenotypic Drug Discovery Special Interest Group (SIG)

Tuesday, February 6
8:00 AM - 9:15 AM
Location: 11B

The phenotypic drug discovery (PDD) SIG will serve as a discussion forum for the global research community to share/discuss/debate topics related to PDD research. Participants will share their experiences, perceptions, and thoughts on the advantages/disadvantages of PDD and whether/how PDD complements targeted drug discovery (TDD) strategies. Related topics such as target identification/validation, chemical diversity, chemical genomics, chemo-informatics, poly-pharmacology, translational pharmacology, biological model systems and patient tailoring are also in scope.

Jonathan Lee

Senior Research Advisor
Eli Lilly

Presentation(s):

Send Email for Jonathan Lee


Assets

Phenotypic Drug Discovery Special Interest Group (SIG)



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Phenotypic Drug Discovery Special Interest Group (SIG)